Terug
11
Ook genoteerd als
NURAF
OTC
Dagbereik
€ 26,50
€ 27,01
52-Weeksbereik
€ 22,73
€ 43,20
Volume
19.178
50D / 200D Gem.
€ 30,22
/
€ 36,84
Vorige Slotkoers
€ 27,39
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (621 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,2 | 12,3 |
| P/B | 0,0 | 2,9 |
| ROE % | 22,5 | 8,9 |
| Net Margin % | 12,3 | 5,6 |
| Rev Growth 5Y % | 8,6 | 9,2 |
| D/E | 0,6 | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 214,48
€ 209,78 – € 217,61
|
870 B | 1 |
| FY2026 |
€ 181,60
€ 180,03 – € 183,17
|
810 B | 1 |
Belangrijkste Punten
Revenue grew 8,58% annually over 5 years — modest growth
Earnings grew 17,73% over the past year
ROE of 22,50% indicates high profitability
Generating 80,59B in free cash flow
P/E of 0,16 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,74%
Groei
Revenue Growth (5Y)
8,58%
Revenue (1Y)3,84%
Earnings (1Y)17,73%
FCF Growth (3Y)12,04%
Kwaliteit
Return on Equity
22,50%
ROIC14,35%
Net Margin12,26%
Op. Margin17,64%
Veiligheid
Debt / Equity
0,62
Current Ratio1,75
Interest Coverage23,25
Waardering
P/E Ratio
0,16
P/B Ratio0,04
EV/EBITDA0,87
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,84% | Revenue Growth (3Y) | 5,12% |
| Earnings Growth (1Y) | 17,73% | Earnings Growth (3Y) | 10,85% |
| Revenue Growth (5Y) | 8,58% | Earnings Growth (5Y) | 15,40% |
| Profitability | |||
| Revenue (TTM) | 764,81B | Net Income (TTM) | 93,76B |
| ROE | 22,50% | ROA | 10,10% |
| Gross Margin | 36,00% | Operating Margin | 17,64% |
| Net Margin | 12,26% | Free Cash Flow (TTM) | 80,59B |
| ROIC | 14,35% | FCF Growth (3Y) | 12,04% |
| Safety | |||
| Debt / Equity | 0,62 | Current Ratio | 1,75 |
| Interest Coverage | 23,25 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 0,16 | P/B Ratio | 0,04 |
| P/S Ratio | 0,02 | PEG Ratio | 1,52 |
| EV/EBITDA | 0,87 | Dividend Yield | 0,01% |
| Market Cap | 15,19B | Enterprise Value | 117,62B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764,81B | 736,56B | 692,17B | 611,63B | 550,34B |
| Net Income | 93,76B | 79,64B | 76,31B | 71,45B | 52,87B |
| EPS (Diluted) | 163,56 | 136,84 | 128,88 | 120,34 | 88,12 |
| Gross Profit | 275,30B | 261,01B | 239,83B | 216,07B | 185,80B |
| Operating Income | 134,91B | 120,41B | 111,83B | 102,54B | 87,43B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 928,50B | 922,77B | 838,22B | 789,66B | 656,54B |
| Total Liabilities | 490,54B | 519,75B | 435,81B | 447,17B | 323,33B |
| Shareholders' Equity | 434,04B | 399,53B | 399,01B | 339,36B | 330,50B |
| Total Debt | 271,02B | 298,54B | 237,74B | 250,42B | 165,59B |
| Cash & Equivalents | 168,60B | 173,94B | 129,26B | 115,61B | 153,19B |
| Current Assets | 419,42B | 405,18B | 349,10B | 333,65B | 323,37B |
| Current Liabilities | 239,48B | 214,64B | 198,25B | 298,34B | 174,35B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#534 of 670
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026